Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #10,931 to #10,980.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Neuraxis (1 revision)
  2. Neuregulin 2 (1 revision)
  3. Neurexophilin and pc-esterase domain family member 2 (1 revision)
  4. NeuroArm (1 revision)
  5. NeuroNames (1 revision)
  6. Neuroactive steroid (1 revision)
  7. Neuroblast (1 revision)
  8. Neuroblastoma highly expressed 1 (1 revision)
  9. Neurocalcin (1 revision)
  10. Neurocan (1 revision)
  11. Neurocardiogenic syncope causes (1 revision)
  12. Neurocardiogenic syncope risk factors (1 revision)
  13. Neurodegeneration with brain iron accumulation (1 revision)
  14. Neurodegenerative disease (1 revision)
  15. Neurodermatitis (1 revision)
  16. Neuroeconomics (1 revision)
  17. Neuroendocrine tumors natural history (1 revision)
  18. Neuroendocrine tumors secondary prevention (1 revision)
  19. Neuroendocrinology (1 revision)
  20. Neurofibroma case study one (1 revision)
  21. Neurofibroma natural history (1 revision)
  22. Neurofibromatosis type 1 cost-effectiveness of therapy (1 revision)
  23. Neurofibromatosis type 1 future or investigational therapies (1 revision)
  24. Neurofibromatosis type 1 other imaging findings (1 revision)
  25. Neurofibromatosis type 1differential diagnosis (1 revision)
  26. Neurogastroenterology (1 revision)
  27. Neurogenic locus notch homolog protein 4 (1 revision)
  28. Neurogenin-1 (1 revision)
  29. Neurogenin-2 (1 revision)
  30. Neurogenin-3 (1 revision)
  31. Neuroglycopenia (patient information) (1 revision)
  32. Neuroglycopenia CT (1 revision)
  33. Neuroglycopenia MRI (1 revision)
  34. Neuroglycopenia case study one (1 revision)
  35. Neuroglycopenia causes (1 revision)
  36. Neuroglycopenia classification (1 revision)
  37. Neuroglycopenia cost-effectiveness of therapy (1 revision)
  38. Neuroglycopenia differential diagnosis (1 revision)
  39. Neuroglycopenia electrocardiogram (1 revision)
  40. Neuroglycopenia epidemiology and demographics (1 revision)
  41. Neuroglycopenia future or investigational therapies (1 revision)
  42. Neuroglycopenia laboratory findings (1 revision)
  43. Neuroglycopenia medical therapy (1 revision)
  44. Neuroglycopenia natural history, complications and prognosis (1 revision)
  45. Neuroglycopenia other diagnostic studies (1 revision)
  46. Neuroglycopenia other imaging findings (1 revision)
  47. Neuroglycopenia overview (1 revision)
  48. Neuroglycopenia pathophysiology (1 revision)
  49. Neuroglycopenia physical examination (1 revision)
  50. Neuroglycopenia primary prevention (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)